{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:30:58Z","timestamp":1763415058386},"reference-count":45,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2015,10,29]]},"abstract":"<jats:p>Normal pressure hydrocephalus (NPH) is one of a few treatable conditions of cognitive decline affecting predominately elderly people. Treatment, commonly based on the ventriculoperitoneal shunt insertion, leads to a partial or complete correction of patient's state, although its effect does not unfortunately always last. The aim of our study was to observe the changes of homocysteine and selected steroids and neurosteroids and follow-up the patients with respect to the duration of the NPH-related dementia improvement. The cerebrospinal fluid and plasma levels of cortisol, cortisone, dehydroepiandrosterone (DHEA), 7\u03b1-hydroxy-DHEA, 7\u03b2-hydroxy-DHEA, 7-oxo-DHEA, 16\u03b1-hydroxy-DHEA (all LC-MS\/MS), DHEA-sulphate (DHEAS) (radioimmunoassay) and homocysteine (gas chromatography) were determined in NPH-diagnosed subjects before, during and 6, 12 and 24 months after shunt insertion. The cognitive functions ameliorated after shunt insertion and remain improved within 2 years. Changes in cerebrospinal fluid DHEAS, DHEA and its ratio, cortisone\/cortisol and 16\u03b1-hydroxy-DHEA and plasma DHEAS, 7\u03b2-hydroxy-DHEA, cortisone\/cortisol and homocysteine were found. Mentioned changes may contribute to the clarification of NPH pathogenesis. Altered neurosteroids levels are possible indicators to be utilized in the follow-up of NPH subjects. Moreover, plasma homocysteine may serve as an early indicator of NPH-related dementia.<\/jats:p>","DOI":"10.33549\/physiolres.933072","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T12:55:10Z","timestamp":1587473710000},"page":"S227-S236","source":"Crossref","is-referenced-by-count":7,"title":["Steroid Hormones and Homocysteine in the Outcome of Patients With Normal Pressure Hydrocephalus"],"prefix":"10.33549","author":[{"given":"L.","family":"SOSVOROVA","sequence":"first","affiliation":[{"name":"Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"MOHAPL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"HILL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"STARKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"BICIKOVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"VITKU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"KANCEVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"BESTAK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"HAMPL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"BERAN O, DZUPOVA O, HOLUB M: Cortisol kinetics in cerebrospinal fluid during bacterial meningitis. J Clin Neurosci 18: 1001-1002, 2011.","DOI":"10.1016\/j.jocn.2010.12.020"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"BERGSNEIDER M, BLACK PM, KLINGE P, MARMAROU A, RELKIN N: Surgical management of idiopathic normal-pressure hydrocephalus. Neurosurgery 57: S29-S39; discussion ii-v, 2005.","DOI":"10.1227\/01.neu.0000168186.45363.4d"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"BI\u010c\u00cdKOV\u00c1 M, \u0158\u00cdPOV\u00c1 D, HILL M, JIR\u00c1K R, HAVL\u00cdKOV\u00c1 H, TALLOV\u00c1 J, HAMPL R: Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer\u2019s disease and vascular dementia. Clin Chem Lab Med 42: 518-524, 2004.","DOI":"10.1515\/cclm.2004.088"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"BROWN RC, HAN Z, CASCIO C, PAPADOPOULOS V: Oxidative stress-mediated DHEA formation in Alzheimer\u2019s disease pathology. Neurobiol Aging 24: 57-65, 2003.","DOI":"10.1016\/s0197-4580(02)00048-9"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"CORPECHOT C, ROBEL P, AXELSON M, SJOVALL J, BAULIEU EE: Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 78: 4704-4707, 1981.","DOI":"10.1073\/pnas.78.8.4704"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"EL KIHEL L: Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)-recent reports. Steroids 77: 10-26, 2012.","DOI":"10.1016\/j.steroids.2011.09.008"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"FERROUD C, REVIAL G, MORFIN R: Chemical and biochemical approaches to the production of 7-hydroxylated C19-steroids. Horm Mol Biol Clin Invest 10: 293-299, 2012.","DOI":"10.1515\/hmbci-2012-0013"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"FORNER GINER J, SANZ-REQUENA R, FLOREZ N, ALBERICH-BAYARRI A, GARCIA-MARTI G, PONZ A, MARTI-BONMATI L: Quantitative phase-contrast MRI study of cerebrospinal fluid flow: a method for identifying patients with normal-pressure hydrocephalus. Neurologia 29: 68-75, 2014.","DOI":"10.1016\/j.nrleng.2013.12.006"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"GIATTI S, GARCIA-SEGURA LM, MELCANGI RC: New steps forward in the neuroactive steroid field. J Steroid Biochem Mol Biol 153: 127-134, 2015.","DOI":"10.1016\/j.jsbmb.2015.03.002"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"GUAZZO EP, KIRKPATRICK PJ, GOODYER IM, SHIERS HM, HERBERT J: Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 81: 3951-3960, 1996.","DOI":"10.1210\/jcem.81.11.8923843"},{"key":"ref10","unstructured":"HAMPL R, HILL M, ST\u00c1RKA L: DHEA metabolites during the life span. In: DHEA and the Brain. MORFIN R (ed), Taylor & Francis, London and New York, 2003."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"HOLMES MC, SECKL JR: The role of 11beta-hydroxysteroid dehydrogenases in the brain. Mol Cell Endocrinol 248: 9-14, 2006.","DOI":"10.1016\/j.mce.2005.12.002"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"HU\u0160EK P, MATUCHA P, VR\u00c1NKOV\u00c1 A, \u0160IMEK P: Simple plasma work-up for a fast chromatographic analysis of homocysteine, cysteine, methionine and aromatic amino acids. J Chromatography B 789: 311-322, 2003.","DOI":"10.1016\/s1570-0232(03)00104-1"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"ISOBE C, MURATA T, SATO C, TERAYAMA Y: Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease. Life Sci 77: 1836-1843, 2005.","DOI":"10.1016\/j.lfs.2005.02.014"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"JARAJ D, RABIEI K, MARLOW T, JENSEN C, SKOOG I, WIKKELSO C: Prevalence of idiopathic normal-pressure hydrocephalus. Neurology 82: 1449-1454, 2014.","DOI":"10.1212\/wnl.0000000000000342"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"KANCHEVA R, HILL M, NOVAK Z, CHRASTINA J, VELIKOVA M, KANCHEVA L, RIHA I, STARKA L: Peripheral neuroactive steroids may be as good as the steroids in the cerebrospinal fluid for the diagnostics of CNS disturbances. J Steroid Biochem Mol Biol 119: 35-44, 2010.","DOI":"10.1016\/j.jsbmb.2009.12.006"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"KAZUI H, MORI E, OHKAWA S, OKADA T, KONDO T, SAKAKIBARA R, UEKI O, NISHIO Y, ISHII K, KAWAGUCHI T, ISHIKAWA M, TAKEDA M: Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery. J Neurol Sci 328: 64-69, 2013.","DOI":"10.1016\/j.jns.2013.02.020"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"KIM SB, HILL M, KWAK YT, HAMPL R, JO DH, MORFIN R: Neurosteroids: cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics. J Clin Endocrinol Metab 88: 5199-5206, 2003.","DOI":"10.1210\/jc.2003-030646"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"KLINGE P, HELLSTROM P, TANS J, WIKKELSO C: One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand 126: 145-153, 2012.","DOI":"10.1111\/j.1600-0404.2012.01676.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"KOIVISTO AM, ALAFUZOFF I, SAVOLAINEN S, SUTELA A, RUMMUKAINEN J, KURKI M, J\u00c4\u00c4SKEL\u00c4INEN JE, SOININEN H, RINNE J, LEINONEN V: Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus. Neurosurgery 72: 1-8, 2013.","DOI":"10.1227\/neu.0b013e31827414b3"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"LEENEN FH: The central role of the brain aldosterone-\u201couabain\u201d pathway in salt-sensitive hypertension. Biochim Biophys Acta 1802: 1132-1139, 2010.","DOI":"10.1016\/j.bbadis.2010.03.004"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"LUCHETTI S, BOSSERS K, VAN DE BILT S, AGRAPART V, MORALES RR, FRAJESE GV, SWAAB DF: Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease. Neurobiol Aging 32: 1964-1976, 2011.","DOI":"10.1016\/j.neurobiolaging.2009.12.014"},{"key":"ref22","unstructured":"MELLON SH: DHEA and brain development. In: DHEA and the Brain. MORFIN R (ed), Taylor & Francis, London and New York, 2003."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"MORFIN R, STARKA L: Neurosteroid 7-hydroxylation products in the brain. Int Rev Neurobiol 46: 79-95, 2001.","DOI":"10.1016\/s0074-7742(01)46059-4"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"MULLER C, POMPON D, URBAN P, MORFIN R: Inter-conversion of 7alpha- and 7beta-hydroxy-dehydroepiandrosterone by the human 11beta-hydroxysteroid dehydrogenase type 1. J Steroid Biochem Mol Biol 99: 215-222, 2006.","DOI":"10.1016\/j.jsbmb.2005.12.001"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"NAYLOR JC, HULETTE CM, STEFFENS DC, SHAMPINE LJ, ERVIN JF, PAYNE VM, MASSING MW, KILTS JD, STRAUSS JL, CALHOUN PS, CALNAIDO RP, BLAZER DG, LIEBERMAN JA, MADISON RD, MARX CE: Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab 93: 3173-3178, 2008.","DOI":"10.1210\/jc.2007-1229"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"NIGIM F, CRITCHLOW JF, SCHNEIDER BE, CHEN C, KASPER EM: Shunting for hydrocephalus: analysis of techniques and failure patterns. J Surg Res 191: 140-147, 2014.","DOI":"10.1016\/j.jss.2014.03.075"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"POCA MA, SOLANA E, MARTINEZ-RICARTE FR, ROMERO M, GANDARA D, SAHUQUILLO J: Idiopathic normal pressure hydrocephalus: results of a prospective cohort of 236 shunted patients. Acta Neurochir Suppl 114: 247-253, 2012.","DOI":"10.1007\/978-3-7091-0956-4_49"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"POPP J, WOLFSGRUBER S, HEUSER I, PETERS O, HULL M, SCHRODER J, MOLLER HJ, LEWCZUK P, SCHNEIDER A, JAHN H, LUCKHAUS C, PERNECZKY R, FROLICH L, WAGNER M, MAIER W, WILTFANG J, KORNHUBER J, JESSEN F: Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Neurobiol Aging 36: 601-607, 2015.","DOI":"10.1016\/j.neurobiolaging.2014.10.031"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"POUZAR V, \u010cERN\u00dd I, HILL M, BI\u010c\u00cdKOV\u00c1 M, HAMPL R: Derivatives of 16\u03b1-hydroxy-dehydroepiandrosterone with an additional 7-oxo or 7-hydroxy substituent: synthesis and gas chromatography\/mass spectrometry analysis. Steroids 70: 739-749, 2005.","DOI":"10.1016\/j.steroids.2005.04.002"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"REDDY GK, BOLLAM P, CALDITO G: Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus. World Neurosurg 81: 404-410, 2014.","DOI":"10.1016\/j.wneu.2013.01.096"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"RELKIN N, MARMAROU A, KLINGE P, BERGSNEIDER M, BLACK PM: Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57: 4-16, 2005.","DOI":"10.1227\/01.neu.0000168185.29659.c5"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"RIGAMONTI D: Adult Hydrocephalus. Cambridge University Press, New York, 2014.","DOI":"10.1017\/CBO9781139382816"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"ROBINZON B, MICHAEL KK, RIPP SL, WINTERS SJ, PROUGH RA: Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases? Arch Biochem Biophys 412: 251-258, 2003.","DOI":"10.1016\/s0003-9861(03)00056-0"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"SECKL JR, WALKER BR: 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrin Med 15: 418-424, 2004.","DOI":"10.1016\/j.tem.2004.09.007"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"SESHADRI S, BEISER A, SELHUB J, JACQUES PF, ROSENBERG IH, D'AGOSTINO RB, WILSON PW, WOLF PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl J Med 346: 476-483, 2002.","DOI":"10.1056\/nejmoa011613"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"SINCLAIR AJ, WALKER EA, BURDON MA, VAN BEEK AP, KEMA IP, HUGHES BA, MURRAY PI, NIGHTINGALE PG, STEWART PM, RAUZ S, TOMLINSON JW: Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? J Clin Endocrinol Metab 95: 5348-5356, 2010.","DOI":"10.1210\/jc.2010-0729"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"SOSVOROVA L, BESTAK J, BICIKOVA M, MOHAPL M, HILL M, KUBATOVA J, HAMPL R: Determination of homocysteine in cerebrospinal fluid as an indicator for surgery treatment in patients with hydrocephalus. Physiol Res 63: 521-527, 2014.","DOI":"10.33549\/physiolres.932650"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"SOSVOROV\u00c1 L, BI\u010c\u00cdKOV\u00c1 M, MOHAPL M, HAMPL R: Steroids and their metabolites in CSF from shunt as potential predictors of further disease progression in patients with hydrocephalus and the importance of 11\u03b2-hydroxysteroid dehydrogenase. Horm Mol Biol Clin Invest 10: 287-292, 2012.","DOI":"10.1515\/hmbci-2012-0002"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"SOSVOROVA L, HILL M, MOHAPL M, VITKU J, HAMPL R: Steroid hormones in prediction of normal pressure hydrocephalus. J Steroid Biochem Mol Biol 152: 124-132, 2015a.","DOI":"10.1016\/j.jsbmb.2015.05.004"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"SOSVOROVA L, VITKU J, CHLUPACOVA T, MOHAPL M, HAMPL R: Determination of seven selected neuro- and immunomodulatory steroids in human cerebrospinal fluid and plasma using LC-MS\/MS. Steroids 98: 1-8, 2015b.","DOI":"10.1016\/j.steroids.2015.01.019"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"ST\u00c1RKA L, DU\u0160KOV\u00c1 M, HILL M: Dehydroepiandrosterone: a neuroactive steroid. J Steroid Biochem Mol Biol 145: 254-260, 2014.","DOI":"10.1016\/j.jsbmb.2014.03.008"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"VITKU J, STARKA L, BICIKOVA M, HILL M, HERACEK J, SOSVOROVA L, HAMPL R: Endocrine disruptors and other inhibitors of 11beta-hydroxysteroid dehydrogenase 1 and 2: tissue-specific consequences of enzyme inhibition. J Steroid Biochem Mol Biol in press 2014.","DOI":"10.1016\/j.jsbmb.2014.07.007"},{"key":"ref43","unstructured":"WALCHENBACH R, GEIGER E, THOMEER RTWM, VANNESTE JAL: The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 72: 503-506, 2002."},{"key":"ref44","unstructured":"WOJTAL K, TROJNAR MK, CZUCZWAR SJ: Endogenous neuroprotective factors: neurosteroids. Pharmacol Rep 58: 335-340, 2006."}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T01:06:13Z","timestamp":1615338373000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomed.cas.cz\/physiolres\/pdf\/64%20Suppl%202\/64_S227.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":45,"URL":"https:\/\/doi.org\/10.33549\/physiolres.933072","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10,14]]}}}